Results 171 to 180 of about 3,625,133 (352)

Author response for "Multicultural coping experiences of parents following perinatal loss: A meta‐ethnographic synthesis"

, 2019
Sara Fernández‐Basanta, Carmen Coronado, María Jesús Movilla Fernández   +2 more
openalex   +1 more source

Decision letter for "<i>In vivo</i> and <i>ex vivo</i> actions of a novel <i>P. gingivalis</i> inhibitor on multi‐species biofilm, inflammatory response and periodontal bone loss"

, 2020

openalex   +1 more source

Intein‐based modular chimeric antigen receptor platform for specific CD19/CD20 co‐targeting

Molecular Oncology, EarlyView.
CARtein is a modular CAR platform that uses split inteins to splice antigen‐recognition modules onto a universal signaling backbone, enabling precise, scarless assembly without re‐engineering signaling domains. Deployed here against CD19 and CD20 in B‐cell malignancies, the design supports flexible multi‐antigen targeting to boost T‐cell activation and
Pablo Gonzalez‐Garcia, Noelia Moares, Wenjie Yi‐He, Rosa Luna‐Espejo, Ricardo Fernandez‐Cisnal, Javier Ocaña‐Cuesta, Juan P. Muñoz‐Miranda, Antonio Gabucio, Cecilia M. Fernandez‐Ponce, Francisco Garcia‐Cozar   +9 more
wiley   +1 more source

Pregnancy outcomes in women at high risk of preterm birth receiving a vaginal cervical cerclage with, or without, progesterone: A retrospective, secondary analysis of the C-STICH randomised controlled trial data. [PDF]

PLoS Med
Hodgetts Morton V, Morris K, Toozs-Hobson P, Middleton L, Pilarski N, Bell L, Hogg M, Man R, Israfil-Bayli F, Shennan A, Simpson N, Lees C, Moakes C.   +12 more
europepmc   +1 more source

Do initial stop-losses stop losses? [PDF]

, 2008
Vanstone, Bruce J
core  

Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107

Molecular Oncology, EarlyView.
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz, Anna L. Bartkowiak, Michael Rose, Nora Kolks, Patrick Petzsch, Vandana Solanki, Anne Stoffel, Bianca Faßbender, Leandra Lepping, Julka Volkamer, Karl Köhrer, Marc Seifert, Tokameh Mahmoudi, Tahlita C. M. Zuiverloon, Günter Niegisch, Michèle J. Hoffmann   +15 more
wiley   +1 more source

The Global Economic Burden of Tuberculosis: Regional Disparities and Implications. [PDF]

Open Forum Infect Dis
Wang JC, Zuo QY, Zheng JX, Lv WW, Wang W, Zhang SX.   +5 more
europepmc   +1 more source

Effect of Nitrogen Sources on Leaching Loss of Potassium in Typic Ustropept Growing Rice [PDF]

, 1994
S. Suresh, V. Velu, P.P. Ramaswami, P. Govindaraju   +3 more
openalex  

Cytoplasmic p21 promotes stemness of colon cancer cells via activation of the NFκB pathway

Molecular Oncology, EarlyView.
Cytoplasmic p21 promotes colorectal cancer stem cell (CSC) features by destabilizing the NFκB–IκB complex, activating NFκB signaling, and upregulating BCL‐xL and COX2. In contrast to nuclear p21, cytoplasmic p21 enhances spheroid formation and stemness transcription factor CD133.
Arnatchai Maiuthed, Kerstin Huebner, Katharina Erlenbach‐Wuensch, Chuanpit Hampel, Daniela Thalheim, Adriana Vial‐Roehe, Bodee Nutho, Susanne Merkel, Arndt Hartmann, Pithi Chanvorachote, Regine Schneider‐Stock   +10 more
wiley   +1 more source

Productivity losses and treatment cost of benign prostatic hyperplasia in Ghana. [PDF]

PLoS One
Dadee-Seshie DS, Agbeteti SG, Kpankyaano B, Adamu AF, Adanu SK, Alhassan Y, Dalaba MA, Adanu KK.   +7 more
europepmc   +1 more source